Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01871389 · ClinicalTrials.gov registry record
Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects
A clinical trial of Bariatric Surgery, sponsored by Texas Tech University.
- Completed
- Registry status
- 31
- Enrollment target
- 1
- Study location
NCT01871389: Completed study of Bariatric Surgery, sponsored by Texas Tech University.
NCT01871389 is a study of Bariatric Surgery that has completed, run by Texas Tech University. The registered enrollment target is 31 participants, below the 97-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01871389, a study of Bariatric Surgery, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitamin D deficiency is common after bariatric surgery. This study is designed to determine if a high dose monthly supplement of vitamin D 3 will be effective in helping improve vitamin D status after surgery such as gastric bypass. Bariatric surgery subjects taking monthly high dose cholecalciferol supplements in addition to the standard vitamin D protocol will have a significant rise in serum vitamin D levels compared to the subjects taking only the usual vitamin D protocol.
Conditions Studied
Study Locations (1)
Texas
- Advanced Bariatric Surgery Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-08 |
What the finished NCT01871389 record still lists
NCT01871389 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 97-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Bariatric Surgery appearing as the primary indexed condition, and to 0 interventions.
NCT01871389 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01871389 about?
NCT01871389 is a clinical study titled "Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects". Vitamin D deficiency is common after bariatric surgery. This study is designed to determine if a high dose monthly supplement of vitamin D 3 will be effective in helping improve vitamin D status after surgery such as gastric bypass. Bariatric surgery subjects taking monthly high dose cholecalciferol...
What is the current status of trial NCT01871389?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2012-02. Estimated completion is 2013-08.
What conditions does trial NCT01871389 study?
This clinical trial studies the following conditions: Bariatric Surgery.
Who is sponsoring clinical trial NCT01871389?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01871389 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01871389's enrollment target sits among peer trials
31 14th of 15 higher than 2 of 15 other Bariatric Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
RECRUITING · Phase 1
-
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
RECRUITING · Phase 2
-
2024 Tirzepatide-Bariatric Surgery
RECRUITING · Phase 4
-
Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery
RECRUITING · NA
-
Simethicone as Part of ERAS in Bariatric Surgery Patients
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia